Long-term clinical results of MR-guided stereotactic body radiotherapy of liver metastases
Magnetic-resonance (MR)-guided stereotactic body radiotherapy (SBRT) allows for ablative, non-invasive treatment of liver metastases. However, long-term clinical outcome data are missing.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 May 2023
|
| In: |
Cancers
Year: 2023, Volume: 15, Issue: 10, Pages: 1-10 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15102786 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers15102786 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/15/10/2786 |
| Author Notes: | Fabian Weykamp, Philipp Hoegen, Sebastian Regnery, Efthimios Katsigiannopulos, C. Katharina Renkamp, Kristin Lang, Laila König, Elisabetta Sandrini, Eva Meixner, Carolin Rippke, Carolin Buchele, Jakob Liermann, Jürgen Debus, Sebastian Klüter and Juliane Hörner-Rieber |
| Summary: | Magnetic-resonance (MR)-guided stereotactic body radiotherapy (SBRT) allows for ablative, non-invasive treatment of liver metastases. However, long-term clinical outcome data are missing. |
|---|---|
| Item Description: | Gesehen am 21.11.2023 |
| Physical Description: | Online Resource |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers15102786 |